3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
10
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
7
Esophageal Squamous Cell Carcinoma
3
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Advanced Gastric Adenocarcinoma
2
Uterine Cervical Neoplasms
1
Turcot syndrome
1
Stomach Neoplasms
1
Recurrence
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Liver Diseases
1
Leukemia, Myeloid, Acute
1
Immune Checkpoint Inhibition
1
ESCC
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Bites and Stings
1
Advanced Hepatocellular Carcinoma
1
Interventions
Colonoscopy
44
Standard of Care
29
Early Intervention, Educational
23
Methods
22
Blood Specimen Collection
21
Exercise
20
Educational Status
19
Interviews as Topic
13
Surveys and Questionnaires
12
Practice Guidelines as Topic
12
Patient Navigation
12
Counseling
12
Endoscopic Mucosal Resection
10
Drug Therapy
10
Oxaliplatin
9
Irinotecan
8
Fluorouracil
8
Surgical Procedures, Operative
7
Preoperative Exercise
7
Lidocaine
7
Bevacizumab
7
Therapeutics
6
Resistance Training
6
Occult Blood
6
Narrow Band Imaging
6
Mass Screening
6
Leucovorin
6
Diet
6
Decision Support Techniques
6
Control Groups
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Colorectal Neoplasms
×
camrelizumab
×
Clear all
NCT05202314
2023-02-21
NACSOC-02
Beijing Chao Yang Hospital
Phase NA
Recruiting
20 enrolled